Characteristics of the First 102 Severe COVID-19 Cases Treated With Convalescent Plasma or Tocilizumab or Both in Al-Nahdha Hospital, Oman

BACKGROUND: In the absence of an effective vaccine, the coronavirus disease (COVID-19) continues to cause more deaths. Evidence on the effectiveness of various COVID-19 management plans is inconclusive. This paper describes the characteristics of the first 102 severe COVID-19 in-patients treated wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Harthi, Saud, Osali, Magdi Al, Kindi, Nasser Al, Kharusi, Zahir Al, Qasabi, Salim Al, Hinai, Mohamed Al, Ghafri, Thamra Al
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878948/
https://www.ncbi.nlm.nih.gov/pubmed/33623809
http://dx.doi.org/10.1177/2333392820986639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878948/
https://www.ncbi.nlm.nih.gov/pubmed/33623809
http://dx.doi.org/10.1177/2333392820986639

Ejemplares similares